Heligenics - Connecting Mutations to Health

Heligenics is a life sciences company that has developed proprietary technology, which shows the impact of genetic mutations to revolutionize genetic testing and drug development for major diseases. We are the first company to develop High Content Screening for Biologic Drugs, previously the mainstay for the development of small compound drugs. As the effect of most mutations on gene function is largely unknown, Heligenics comprehensively measures the functional significance of mutations in the human genome through a massively parallel in-vitro process called the GigaAssay, measuring the impact of all potential amino acid substitutions in the functional target protein, doing in...

Drug discovery,cancer variant interpretation,functional genomics,and saturating mutagenesis

Heligenics - connecting mutations to health operates in the Biotechnology research industry.

Heligenics - connecting mutations to health's revenue is 1m - 10m

Heligenics - connecting mutations to health has 11 - 50 employees.